2m 2m 2m 2m 2m 2m 2m
Kairos Pharma (KAPA)
NYSE
$1.80+$0.04 (+2.39%)
Price as of Sep 11, 2026 7:56 PM EDT- $6.0MMarket Cap
- -85.73%1-Year Change
- BiotechnologyIndustry
Kairos Pharma (KAPA)
$1.80+$0.04 (+2.39%)
KAPA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.76 | ||
Change | +$0.08 (+4.64%) | ||
Open | $1.69 | ||
High | $1.76 | ||
Low | $1.67 | ||
Previous Close | $1.68 | ||
Volume | 33,200 | ||
30-Day Average Volume | 77,677 | ||
1-Week Change | -4.46% | ||
1-Month Change | -30.89% | ||
1-Year Change | -85.73% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 3.4M | ||
Total Assets | $4.5M | ||
Market Cap | $6.0M | ||
Enterprise Value | $3.3M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | -$1.0M | ||
EBIT | $0.00 | ||
EBITDA | $22,000.00 | ||
Net Working Capital | $2.9M | ||
EPS | -$0.42 | ||
Enterprise Value/EBITDA | 151 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -4 | ||
PEG | -0 | ||
Price/Free Cash Flow | -6 | ||
Price/Operating Cash Flow | -6 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 7 | ||
Last Split Date | 09/01/2026 | ||
Earnings & Revenue